Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors

被引:18
|
作者
Ghosh, Arun K. [1 ,2 ]
Chapsal, Bruno D. [1 ,2 ]
Steffey, Melinda [1 ,2 ]
Agniswamy, Johnson [3 ]
Wang, Yuan-Fang [3 ]
Amano, Masayuki [4 ,5 ]
Weber, Irene T. [3 ]
Mitsuya, Hiroaki [4 ,5 ,6 ]
机构
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
[3] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[4] Kumamoto Univ, Dept Hematol, Grad Sch Med & Pharmaceut Sci, Kumamoto 8608556, Japan
[5] Kumamoto Univ, Dept Infect Dis, Grad Sch Med & Pharmaceut Sci, Kumamoto 8608556, Japan
[6] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
HIV-1 protease inhibitors; P2; ligand; Drug resistance; Design and synthesis; X-ray crystal structure; DRUG-RESISTANT MUTANTS; BIOLOGICAL EVALUATION; P2-LIGANDS; BACKBONE;
D O I
10.1016/j.bmcl.2012.01.061
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design, synthesis, and biological evaluation of novel C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)-derived HIV-1 protease inhibitors are described. Various C3-functional groups on the Cp-THF ligand were investigated in order to maximize the ligand-binding site interactions in the flap region of the protease. Inhibitors 3c and 3d have displayed the most potent enzyme inhibitory and antiviral activity. Both inhibitors have maintained impressive activity against a panel of multidrug resistant HIV-1 variants. A high-resolution X-ray crystal structure of 3c-bound HIV-1 protease revealed a number of important molecular insights into the ligand-binding site interactions. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2308 / 2311
页数:4
相关论文
共 50 条
  • [21] Probing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological Evaluation
    Ghosh, Arun K.
    Osswald, Heather L.
    Glauninger, Kristof
    Agniswamy, Johnson
    Wang, Yuan-Fang
    Hayashi, Hironori
    Aoki, Manabu
    Weber, Irene T.
    Mitsuya, Hiroaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (14) : 6826 - 6837
  • [22] Potent HIV-1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein-Ligand X-ray Structural Studies
    Ghosh, Arun K.
    Xia, Zilei
    Kovela, Satish
    Robinson, William L.
    Johnson, Megan E.
    Kneller, Daniel W.
    Wang, Yuan-Fang
    Aoki, Manabu
    Takamatsu, Yuki
    Weber, Irene T.
    Mitsuya, Hiroaki
    CHEMMEDCHEM, 2019, 14 (21) : 1863 - 1872
  • [23] Design and synthesis of potent HIV-1 protease inhibitors with (S)-tetrahydrofuran-tertiary amine-acetamide as P2-ligand: Structure-activity studies and biological evaluation
    Bai, Xiaoguang
    Yang, Zhiheng
    Zhu, Mei
    Dong, Biao
    Zhou, Lei
    Zhang, Guoning
    Wang, Juxian
    Wang, Yucheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 137 : 30 - 44
  • [24] Nature Inspired Molecular Design: Stereoselective Synthesis of Bicyclic and Polycyclic Ethers for Potent HIV-1 Protease Inhibitors
    Ghosh, Arun K.
    Brindisi, Margherita
    ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2018, 7 (08) : 1448 - 1466
  • [25] Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation
    Ghosh, Arun K.
    Williams, Jacqueline N.
    Kovela, Satish
    Takayama, Jun
    Simpson, Hannah M.
    Walters, D. Eric
    Hattori, Shin-ichiro
    Aoki, Manabu
    Mitsuya, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (18) : 2565 - 2570
  • [26] Synthesis and biological evaluation of new HIV-1 protease inhibitors with purine bases as P2-ligands
    Zhu, Mei
    Dong, Biao
    Zhang, Guo-Ning
    Wang, Ju-Xian
    Cen, Shan
    Wang, Yu-Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (12) : 1541 - 1545
  • [27] Design of HIV-1 Protease Inhibitors with Pyrrolidinones and Oxazolidinones as Novel P1′-Ligands To Enhance Backbone-Binding Interactions with Protease: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies∞
    Ghosh, Arun K.
    Leshchenko-Yashchuk, Sofiya
    Anderson, David D.
    Baldridge, Abigail
    Noetzel, Marcus
    Miller, Heather B.
    Tie, Yunfeng
    Wang, Yuan-Fang
    Koh, Yasuhiro
    Weber, Irene T.
    Mitsuya, Hiroaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (13) : 3902 - 3914
  • [28] An enzymatic route to the synthesis of tricyclic fused hexahydrofuranofuran P 2-Ligand for a series of highly potent HIV-1 protease inhibitors
    Ghosh, Arun K.
    Sharma, Ashish
    Ghazi, Somayeh
    TETRAHEDRON LETTERS, 2024, 140
  • [29] Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein Ligand X-ray Studies
    Ghosh, Arun K.
    Martyr, Cuthbert D.
    Osswald, Heather L.
    Sheri, Venkat Reddy
    Kassekert, Luke A.
    Chen, Shujing
    Agniswamy, Johnson
    Wang, Yuan-Fang
    Hayashi, Hironori
    Aoki, Manabu
    Weber, Irene T.
    Mitsuya, Hiroaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (17) : 6994 - 7006
  • [30] Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands
    Zhu, Mei
    Du, Xiao-Nan
    Li, Yun-Ge
    Zhang, Guo-Ning
    Wang, Ju-Xian
    Wang, Yu-Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (03) : 357 - 361